Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Impact of Moderate Sodium Restriction and Hydrochlorothiazide on Iodine Excretion in Diabetic Kidney Disease: Data from a Randomized Cross-Over Trial.

Binnenmars SH, Corpeleijn E, Kwakernaak AJ, Touw DJ, Kema IP, Laverman GD, Bakker SJL, Navis G.

Nutrients. 2019 Sep 12;11(9). pii: E2204. doi: 10.3390/nu11092204.

2.

Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function.

Yeung SMH, Binnenmars SH, Gant CM, Navis G, Gansevoort RT, Bakker SJL, de Borst MH, Laverman GD.

Diabetes Care. 2019 Sep 5. pii: dc190528. doi: 10.2337/dc19-0528. [Epub ahead of print]

PMID:
31488569
3.

Effects of dapagliflozin on urinary metabolites in people with type 2 diabetes.

Mulder S, Heerspink HJL, Darshi M, Kim JJ, Laverman GD, Sharma K, Pena MJ.

Diabetes Obes Metab. 2019 Jul 2. doi: 10.1111/dom.13823. [Epub ahead of print]

PMID:
31264758
4.

Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)-A 20-year observational study.

Gant CM, Mensink I, Binnenmars SH, van der Palen JAM, Bakker SJL, Navis G, Laverman GD.

PLoS One. 2019 Jun 19;14(6):e0218400. doi: 10.1371/journal.pone.0218400. eCollection 2019.

5.

Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors.

Eickhoff MK, Dekkers CCJ, Kramers BJ, Laverman GD, Frimodt-Møller M, Jørgensen NR, Faber J, Danser AHJ, Gansevoort RT, Rossing P, Persson F, Heerspink HJL.

J Clin Med. 2019 May 31;8(6). pii: E779. doi: 10.3390/jcm8060779.

6.

High Dietary Intake of Vegetable Protein Is Associated With Lower Prevalence of Renal Function Impairment: Results of the Dutch DIALECT-1 Cohort.

Oosterwijk MM, Soedamah-Muthu SS, Geleijnse JM, Bakker SJL, Navis G, Binnenmars SH, Gant CM, Laverman GD.

Kidney Int Rep. 2019 Feb 21;4(5):710-719. doi: 10.1016/j.ekir.2019.02.009. eCollection 2019 May.

7.

Requirements of an Application to Monitor Diet, Physical Activity and Glucose Values in Patients with Type 2 Diabetes: The Diameter.

den Braber N, Vollenbroek-Hutten MMR, Oosterwijk MM, Gant CM, Hagedoorn IJM, van Beijnum BF, Hermens HJ, Laverman GD.

Nutrients. 2019 Feb 15;11(2). pii: E409. doi: 10.3390/nu11020409.

8.

Escaping residual albuminuria in hypertension: should we start eplerenone or reduce salt intake?

de Borst MH, Laverman GD, Navis G.

Hypertens Res. 2019 Apr;42(4):583-585. doi: 10.1038/s41440-019-0214-x. Epub 2019 Jan 23. No abstract available.

PMID:
30675039
9.

Effects of Dapagliflozin on Circulating Markers of Phosphate Homeostasis.

de Jong MA, Petrykiv SI, Laverman GD, van Herwaarden AE, de Zeeuw D, Bakker SJL, Heerspink HJL, de Borst MH.

Clin J Am Soc Nephrol. 2019 Jan 7;14(1):66-73. doi: 10.2215/CJN.04530418. Epub 2018 Dec 17.

PMID:
30559106
10.

Emergence of tick-borne encephalitis (TBE) in the Netherlands.

Dekker M, Laverman GD, de Vries A, Reimerink J, Geeraedts F.

Ticks Tick Borne Dis. 2019 Jan;10(1):176-179. doi: 10.1016/j.ttbdis.2018.10.008. Epub 2018 Oct 25.

PMID:
30385073
11.

Detection of carnosinase-1 in urine of healthy individuals and patients with type 2 diabetes: correlation with albuminuria and renal function.

Rodriguez-Niño A, Gant CM, Braun JD, Li X, Zhang S, Albrecht T, Qiu J, Bakker SJL, Laverman GD, Krämer BK, Herold A, Hauske SJ, Yard BA.

Amino Acids. 2019 Jan;51(1):17-25. doi: 10.1007/s00726-018-2602-y. Epub 2018 Jun 30.

PMID:
29961141
12.

Lower Renal Function Is Associated With Derangement of 11-β Hydroxysteroid Dehydrogenase in Type 2 Diabetes.

Gant CM, Minovic I, Binnenmars H, de Vries L, Kema I, van Beek A, Navis G, Bakker S, Laverman GD.

J Endocr Soc. 2018 May 22;2(7):609-620. doi: 10.1210/js.2018-00088. eCollection 2018 Jul 1.

13.

Correlations between plasma strontium concentration, components of calcium and phosphate metabolism and renal function in type 2 diabetes mellitus.

van den Berkhof YS, Gant CM, Maatman R, De Graaf A, Navis GJ, Bakker SJL, Laverman GD.

Eur J Clin Invest. 2018 Sep;48(9):e12987. doi: 10.1111/eci.12987. Epub 2018 Jul 20.

PMID:
29931675
14.

Glycaemic control in the diabetes and Lifestyle Cohort Twente: A cross-sectional assessment of lifestyle and pharmacological management on Hba1c target achievement.

Jalving AC, Gant CM, Binnenmars SH, Soedamah-Muthu SS, Bakker SJL, Navis G, Laverman GD.

Diabetes Obes Metab. 2018 Oct;20(10):2494-2499. doi: 10.1111/dom.13399. Epub 2018 Jun 26.

15.

Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors.

Gant CM, Binnenmars SH, Harmelink M, Soedamah-Muthu SS, Bakker SJL, Navis G, Laverman GD.

Nutr Diabetes. 2018 Apr 25;8(1):24. doi: 10.1038/s41387-018-0028-y.

16.

Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers.

Dekkers CCJ, Petrykiv S, Laverman GD, Cherney DZ, Gansevoort RT, Heerspink HJL.

Diabetes Obes Metab. 2018 Aug;20(8):1988-1993. doi: 10.1111/dom.13301. Epub 2018 Apr 23.

17.

Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes.

Gant CM, Soedamah-Muthu SS, Binnenmars SH, Bakker SJL, Navis G, Laverman GD.

Nutrients. 2018 Mar 5;10(3). pii: E307. doi: 10.3390/nu10030307.

18.

Physical Activity in Patients With Type 2 Diabetes: The Case for Objective Measurement in Routine Clinical Care.

Oosterom N, Gant CM, Ruiterkamp N, van Beijnum BF, Hermens H, Bakker SJL, Navis G, Vollenbroek-Hutten MMR, Laverman GD.

Diabetes Care. 2018 Apr;41(4):e50-e51. doi: 10.2337/dc17-2041. Epub 2018 Feb 6. No abstract available.

PMID:
29432126
19.

Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.

Gant CM, Laverman GD, Vogt L, Slagman MCJ, Heerspink HJL, Waanders F, Hemmelder MH, Navis G; Holland Nephrology Study (HONEST) Network.

BMC Nephrol. 2017 Dec 20;18(1):370. doi: 10.1186/s12882-017-0789-x.

20.

Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.

Petrykiv SI, Laverman GD, Persson F, Vogt L, Rossing P, de Borst MH, Gansevoort RT, de Zeeuw D, Heerspink HJL.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1804-1813. doi: 10.2215/CJN.00390117. Epub 2017 Oct 11. Review.

21.

Does SGLT2 inhibition with dapagliflozin overcome individual therapy resistance to RAAS inhibition?

Petrykiv S, Laverman GD, de Zeeuw D, Heerspink HJL.

Diabetes Obes Metab. 2018 Jan;20(1):224-227. doi: 10.1111/dom.13057. Epub 2017 Aug 8.

PMID:
28685934
22.

Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT).

Gant CM, Binnenmars SH, Berg EVD, Bakker SJL, Navis G, Laverman GD.

Nutrients. 2017 Jul 6;9(7). pii: E709. doi: 10.3390/nu9070709.

23.

Sex differences in renin-angiotensin-aldosterone system affect extracellular volume in healthy subjects.

Toering TJ, Gant CM, Visser FW, van der Graaf AM, Laverman GD, Danser AHJ, Faas MM, Navis G, Lely AT.

Am J Physiol Renal Physiol. 2018 May 1;314(5):F873-F878. doi: 10.1152/ajprenal.00109.2017. Epub 2017 Jun 7.

24.

Increasing evidence of tick-borne encephalitis (TBE) virus transmission, the Netherlands, June 2016.

Weststrate AC, Knapen D, Laverman GD, Schot B, Prick JJ, Spit SA, Reimerink J, Rockx B, Geeraedts F.

Euro Surveill. 2017 Mar 16;22(11). pii: 30482. doi: 10.2807/1560-7917.ES.2017.22.11.30482.

25.

The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients.

Petrykiv SI, Laverman GD, de Zeeuw D, Heerspink HJL.

Diabetes Obes Metab. 2017 Oct;19(10):1363-1370. doi: 10.1111/dom.12936. Epub 2017 Jun 8.

PMID:
28295959
26.

Effects of Direct Renin Blockade on Renal & Systemic Hemodynamics and on RAAS Activity, in Weight Excess and Hypertension: A Randomized Clinical Trial.

Kwakernaak AJ, Roksnoer LC, Lambers Heerspink HJ, van den Berg-Garrelds I, Lochorn GA, van Embden Andres JH, Klijn MA, Kobori H, Danser AH, Laverman GD, Navis GJ.

PLoS One. 2017 Jan 24;12(1):e0169258. doi: 10.1371/journal.pone.0169258. eCollection 2017.

27.

Variability in response to albuminuria-lowering drugs: true or random?

Petrykiv SI, de Zeeuw D, Persson F, Rossing P, Gansevoort RT, Laverman GD, Heerspink HJL.

Br J Clin Pharmacol. 2017 Jun;83(6):1197-1204. doi: 10.1111/bcp.13217. Epub 2017 Feb 1.

28.

Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.

Keyzer CA, van Breda GF, Vervloet MG, de Jong MA, Laverman GD, Hemmelder MH, Janssen WM, Lambers Heerspink HJ, Kwakernaak AJ, Bakker SJ, Navis G, de Borst MH; Holland Nephrology Study (HONEST) Network.

J Am Soc Nephrol. 2017 Apr;28(4):1296-1305. doi: 10.1681/ASN.2016040407. Epub 2016 Nov 17.

29.

Concordance of dietary sodium intake and concomitant phosphate load: Implications for sodium interventions.

Humalda JK, Keyzer CA, Binnenmars SH, Kwakernaak AJ, Slagman MC, Laverman GD, Bakker SJ, de Borst MH, Navis GJ.

Nutr Metab Cardiovasc Dis. 2016 Aug;26(8):689-96. doi: 10.1016/j.numecd.2016.04.012. Epub 2016 Apr 27.

PMID:
27266988
30.

Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.

Keyzer CA, de Jong MA, Fenna van Breda G, Vervloet MG, Laverman GD, Hemmelder M, Janssen WM, Lambers Heerspink HJ, Navis G, de Borst MH; Holland Nephrology Study (HONEST) Network.

Nephrol Dial Transplant. 2016 Jul;31(7):1081-7. doi: 10.1093/ndt/gfv033. Epub 2015 Mar 4. Review.

PMID:
25744274
31.

Distal renal tubular acidosis with multiorgan autoimmunity: a case report.

van den Wildenberg MJ, Hoorn EJ, Mohebbi N, Wagner CA, Woittiez AJ, de Vries PA, Laverman GD.

Am J Kidney Dis. 2015 Apr;65(4):607-10. doi: 10.1053/j.ajkd.2014.09.026. Epub 2014 Dec 18.

32.

Bilateral dacryoadenitis as a presenting symptom of an extra-ocular disease.

van den Wildenberg MJ, Laverman GD, de Vries PA.

Neth J Med. 2014 Jun;72(5):281, 285. No abstract available.

33.

Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial.

Kwakernaak AJ, Krikken JA, Binnenmars SH, Visser FW, Hemmelder MH, Woittiez AJ, Groen H, Laverman GD, Navis G; Holland Nephrology Study (HONEST) Group.

Lancet Diabetes Endocrinol. 2014 May;2(5):385-95. doi: 10.1016/S2213-8587(14)70030-0. Epub 2014 Mar 5.

PMID:
24795252
34.

A false-positive antineutrophil cytoplasmic antibody proteinase 3 test in a patient with pulmonary-renal syndrome.

Agterhuis DE, Mulder AH, Roozendaal C, Stegeman CA, Laverman GD.

J Rheumatol. 2014 May;41(5):1031-3. doi: 10.3899/jrheum.131205. No abstract available.

PMID:
24788467
35.

Quiz page February 2014: swollen kidneys and a pancreatic mass.

Agterhuis DE, Schuurmans EP, Hogenes MC, Laverman GD.

Am J Kidney Dis. 2014 Feb;63(2):A18-21. doi: 10.1053/j.ajkd.2013.06.030. No abstract available.

PMID:
24461682
36.

The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands.

Navis GJ, Blankestijn PJ, Deegens J, De Fijter JW, Homan van der Heide JJ, Rabelink T, Krediet RT, Kwakernaak AJ, Laverman GD, Leunissen KM, van Paassen P, Vervloet MG, Wee PM, Wetzels JF, Zietse R, van Ittersum FJ; BIND-NL investigators.

Nephrol Dial Transplant. 2014 Jun;29(6):1145-50. doi: 10.1093/ndt/gft307. Epub 2013 Oct 22. Review.

PMID:
24151018
37.

Prolonged hypocalcaemia after pamidronate infusion in Riedel's thyroiditis associated hypoparathyroidism.

Boumans D, de Vries PA, Rikken NE, Laverman GD.

Neth J Med. 2013 Oct;71(8):442-3. No abstract available.

38.

Sodium restriction on top of renin-angiotensin-aldosterone system blockade increases circulating levels of N-acetyl-seryl-aspartyl-lysyl-proline in chronic kidney disease patients.

Kwakernaak AJ, Waanders F, Slagman MC, Dokter MM, Laverman GD, de Boer RA, Navis G.

J Hypertens. 2013 Dec;31(12):2425-32. doi: 10.1097/HJH.0b013e328364f5de.

PMID:
24029871
39.

Proprotein convertase subtilisin-kexin type 9 is elevated in proteinuric subjects: relationship with lipoprotein response to antiproteinuric treatment.

Kwakernaak AJ, Lambert G, Slagman MC, Waanders F, Laverman GD, Petrides F, Dikkeschei BD, Navis G, Dullaart RP.

Atherosclerosis. 2013 Feb;226(2):459-65. doi: 10.1016/j.atherosclerosis.2012.11.009. Epub 2012 Nov 29.

PMID:
23261172
40.

Vitamin k intake and plasma desphospho-uncarboxylated matrix Gla-protein levels in kidney transplant recipients.

Boxma PY, van den Berg E, Geleijnse JM, Laverman GD, Schurgers LJ, Vermeer C, Kema IP, Muskiet FA, Navis G, Bakker SJ, de Borst MH.

PLoS One. 2012;7(10):e47991. doi: 10.1371/journal.pone.0047991. Epub 2012 Oct 31.

41.

A spangled colon.

Raghoo R, Laverman GD, Woittiez AJ, van den Hout JH, de Vries PA.

Neth J Med. 2012 Oct;70(8):376-80. No abstract available.

42.

Epstein-Barr virus-positive post-transplant lymphoproliferative disorder of the central nervous system, after renal transplantation with a discrepancy in viral load between peripheral blood and cerebrospinal fluid.

Boersma MN, van der Zanden A, Laverman GD, Sanders JS, de Vries PA.

Transpl Int. 2012 Nov;25(11):e113-6. doi: 10.1111/j.1432-2277.2012.01552.x. Epub 2012 Aug 21.

43.

Indomethacin reduces glomerular and tubular damage markers but not renal inflammation in chronic kidney disease patients: a post-hoc analysis.

de Borst MH, Nauta FL, Vogt L, Laverman GD, Gansevoort RT, Navis G.

PLoS One. 2012;7(5):e37957. doi: 10.1371/journal.pone.0037957. Epub 2012 May 25.

44.

Vitamin K intake and status are low in hemodialysis patients.

Cranenburg EC, Schurgers LJ, Uiterwijk HH, Beulens JW, Dalmeijer GW, Westerhuis R, Magdeleyns EJ, Herfs M, Vermeer C, Laverman GD.

Kidney Int. 2012 Sep;82(5):605-10. doi: 10.1038/ki.2012.191. Epub 2012 May 30.

45.

An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials.

Smink PA, Bakker SJ, Laverman GD, Berl T, Cooper ME, de Zeeuw D, Lambers Heerspink HJ.

J Hypertens. 2012 May;30(5):1022-8. doi: 10.1097/HJH.0b013e32835200f9.

PMID:
22388234
46.

The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria.

Mahmoodi BK, Mulder AB, Waanders F, Spronk HM, Mulder R, Slagman MC, Vogt L, Navis G, Ten Cate H, Kluin-Nelemans HC, Laverman GD.

J Thromb Haemost. 2011 Dec;9(12):2416-23. doi: 10.1111/j.1538-7836.2011.04525.x.

47.

Improvement of sodium status to optimize the efficacy of Renin-Angiotensin system blockade.

Laverman GD, Navis G.

Curr Hypertens Rep. 2011 Dec;13(6):397-9. doi: 10.1007/s11906-011-0234-7.

48.

Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.

Slagman MC, Waanders F, Vogt L, Damman K, Hemmelder M, Navis G, Laverman GD.

Nephrol Dial Transplant. 2012 Mar;27(3):983-90. doi: 10.1093/ndt/gfr408. Epub 2011 Aug 22.

PMID:
21862455
49.

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.

Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD; HOlland NEphrology STudy Group.

BMJ. 2011 Jul 26;343:d4366. doi: 10.1136/bmj.d4366.

50.

Effects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.

Slagman MC, Nguyen TQ, Waanders F, Vogt L, Hemmelder MH, Laverman GD, Goldschmeding R, Navis G.

Clin J Am Soc Nephrol. 2011 Aug;6(8):1845-50. doi: 10.2215/CJN.08190910. Epub 2011 Jul 22.

Supplemental Content

Loading ...
Support Center